...
首页> 外文期刊>Kidney international. >Secular trends in recombinant erythropoietin therapy among the U.S. hemodialysis population: 1990|[ndash]|1996
【24h】

Secular trends in recombinant erythropoietin therapy among the U.S. hemodialysis population: 1990|[ndash]|1996

机译:美国血液透析人群中重组促红细胞生成素治疗的长期趋势:1990 | [ndash] | 1996

获取原文
           

摘要

Secular trends in recombinant erythropoietin therapy among the U.S. hemodialysis population: 1990–1996.BackgroundChronic anemia is a major cause of morbidity among the end-stage renal disease (ESRD) population. Recombinant erythropoietin (rHuEPO) has been recognized as a major advance in the treatment of anemia among the ESRD population. This study examines the secular trends in the use of and response to rHuEPO therapy among severely, moderately and mildly anemic hemodialysis patients.
机译:1990-1996年,美国血液透析人群中重组促红细胞生成素疗法的长期趋势。背景慢性贫血是终末期肾脏病(ESRD)人群发病的主要原因。重组促红细胞生成素(rHuEPO)已被认为是ESRD人群贫血治疗的重大进展。这项研究探讨了在重度,中度和轻度贫血血液透析患者中​​使用和响应rHuEPO治疗的长期趋势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号